HIGHLIGHTS
- who: Colorectal Cancer and colleagues from the Department of Gastroenterology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China, Branch have published the Article: Identi cation and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer, in the Journal: (JOURNAL)
- what: Considering that large studies have explored the value of the m6A-related lncRNA signature for predicting overall survival (OS) in CRC , the authors focused on PFS. The authors developed and validated an m6A-Lnc signature to predict PFS in CRC patients. Dependent ROC analysis was conducted to compare . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.